Edwards Lifesciences Corp
NYSE:EW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Edwards Lifesciences Corp
NYSE:EW
|
US |
|
OKE Precision Cutting Tools Co Ltd
SSE:688308
|
CN |
|
R
|
Resmed Inc
ASX:RMD
|
US |
|
A
|
Apex Development PCL
SET:APEX
|
TH |
|
M
|
Maagh Advertising & Marketing Services Ltd
BSE:543624
|
IN |
|
Le Saunda Holdings Ltd
HKEX:738
|
HK |
|
K
|
K2 F&B Holdings Ltd
HKEX:2108
|
SG |
|
Darktrace PLC
OTC:DRKTF
|
UK |
|
R
|
Renewable Energy Group Inc
F:RBE1
|
US |
|
K
|
Kijcharoen Engineering Electric PCL
SET:KJL
|
TH |
|
Bank KB Bukopin Tbk PT
IDX:BBKP
|
ID |
|
Orchid Island Capital Inc
NYSE:ORC
|
US |
|
C
|
CSP International Fashion Group SpA
MIL:CSP
|
IT |
|
Fox Corp
NASDAQ:FOXA
|
US |
|
C
|
CFI Holding SA
WSE:CFI
|
PL |
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
US |
|
B
|
Bim Son Cement JSC
VN:BCC
|
VN |
|
P
|
Pureun Mutual Savings Bank
KOSDAQ:007330
|
KR |
|
DCC PLC
LSE:DCC
|
IE |
|
Wizz Air Holdings PLC
LSE:WIZZ
|
CH |
Wall Street
Price Targets
EW Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for
EW
is 98.22 USD
with a low forecast of 85.61 USD and a high forecast of 115.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EW's stock price target?
Price Target
98.22
USD
According to Wall Street analysts, the average 1-year price target for
EW
is 98.22 USD
with a low forecast of 85.61 USD and a high forecast of 115.5 USD.
What is Edwards Lifesciences Corp's Revenue forecast?
Projected CAGR
11%
For the last 14 years the
compound annual growth rate for
Edwards Lifesciences Corp's revenue is
10%.
The projected
CAGR
for the next 3 years is
11%.
What is Edwards Lifesciences Corp's Operating Income forecast?
Projected CAGR
15%
For the last 14 years the
compound annual growth rate for
Edwards Lifesciences Corp's operating income is
13%.
The projected
CAGR
for the next 3 years is
15%.
What is Edwards Lifesciences Corp's Net Income forecast?
Projected CAGR
27%
For the last 14 years the
compound annual growth rate for
Edwards Lifesciences Corp's net income is
11%.
The projected
CAGR
for the next 3 years is
27%.
